
New guidelines suggest older individuals should not start taking the drug for heart disease or stroke prevention.
New guidelines suggest older individuals should not start taking the drug for heart disease or stroke prevention.
The study results also show that strokes were far more common among traditional smokers.
But expanding coverage in 2014 was associated with a notable increase in enrollment among individuals with heart failure, study results show.
Penn State investigators have found that foods with 6.5 grams, or about 1.3 teaspoons, were linked to reducing hypertension after 4 weeks.
Rivaroxaban (Xarelto; Janssen) found superior to aspirin in reducing the risk of recurrent stroke or systemic embolism in patients with left ventricular dysfunction.
The AHA emphasizes the importance of looking at a total dietary pattern, including amounts, balance, combinations, and variety of beverages and food consumer regularly.
Deep vein thrombosis can occur with certain medical conditions that affect how the blood clots.
Taking all 3 doses also helped patients experience higher A1C levels than patients who took titrated insulin glargine, clinical trial results show.
If the research is confirmed, it could be a warning sign for women to make diet and lifestyle changes aimed at preventing cardiovascular disease.
Alirocumab (Praluent) is a PCSK9 inhibitor for the treatment of heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease.
Causes of aortic valve stenosis include congenital heart defect, calcium build-up on the valve, and rheumatic fever.
Causes of atrial flutter include hypertension, cardiomyopathy, abnormal heart valve, hypertrophy, hyperthyroidism, and pulmonary embolism.
Adults 40 to 59 years of age should consult their clinician before taking aspirin, and adults 60 years of age and older should stop aspirin use for the prevention of cardiovascular disease.
Evolocumab is a PCSK9 inhibitor indicated to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease.
People who inherit familial hypercholesterolemia from both parents usually develop symptoms in childhood.
The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.
During atrial fibrillation, both of the heart's upper chambers beat chaotically and irregularly without coordination.
Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.
Vascepa is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients.
Study results presented at an American Heart Association conference show that 34% of individuals have high blood pressure.
Monthly treatment with evolocumab reduced LDL-C by a mean of 38% from baseline compared to placebo among patients ages 10 to 17 with heterozygous familial hypercholesterolemia.
Verquvo is a soluble guanylate cyclase stimulator indicated to reduce the risk of cardiovascular death and heart failure.
Surgical procedures and weight-loss drugs combat high hypertension in individuals who are obese or overweight, according to the American Heart Association.
The investigators noted that heart attacks are often caused by the rupturing of vulnerable plaques, defined as plaques with a large lipid core with a thin fibrous cap that serves as a wall or barrier around the plaque to keep it intact.
Pharmacists should stay knowledgeable about recommendations and evidence related to therapies.